The role of bismuth drugs in elevation of Helicobacter pylori infection eradication efficacy

Aim of review. To demonstrate modern potential of bismuth agents administration for increasing of Helicobacter pylori (H. pylori) eradication efficacy. Summary. Prevention of peptic ulcer and stomach cancer makes eradication of H. pylori infection more and more important. At the same time efficacy o...

Full description

Saved in:
Bibliographic Details
Main Author: A. A. Sheptulin
Format: Article
Language:Russian
Published: Gastro LLC 2018-08-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/221
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860269040795648
author A. A. Sheptulin
author_facet A. A. Sheptulin
author_sort A. A. Sheptulin
collection DOAJ
description Aim of review. To demonstrate modern potential of bismuth agents administration for increasing of Helicobacter pylori (H. pylori) eradication efficacy. Summary. Prevention of peptic ulcer and stomach cancer makes eradication of H. pylori infection more and more important. At the same time efficacy of some eradication modes, first of all - that of standard triple therapy, steadily decreases because of growing antibiotic resistance of H. pylori strains, first of all - clarithromycin resistance. The concept that empirical prescription of standard triple therapy should be abandoned in favor of initial H. pylori clarithromycin-resistance testing by culture or real-time polymerase chain reaction became widely accepted. Bismuth-based quadrotherapy mainly - with bismuth tripotassium dicitrate (BTD) is alternative to standard triple mode therapy nowadays. Potential of BTD combination not only to tetracycline but to other antibiotics as well was demonstrated. Addition of BTD to triple therapy containing clarithromycin, levofloxacin, metronidazole allows to increase eradication efficacy for 30-40% at H. pylori-resistant strains. Absence of H. pylori resistance development to BTD, combined antibacterial and cytoprotective effects as well as good tolerance are important advantages of the drug. Conclusion. Addition of BTD to triple H. pylori eradication modes, that include different antibiotics (clarithromycin, levofloxacin and metronidazole) provide significant increase in efficacy of eradication at antibioticresistant Helicobacter pylori strains.
format Article
id doaj-art-36bb986abbf24cf787fd0215f0a5e7d0
institution Kabale University
issn 1382-4376
2658-6673
language Russian
publishDate 2018-08-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj-art-36bb986abbf24cf787fd0215f0a5e7d02025-02-10T16:14:29ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732018-08-01281899310.22416/1382-4376-2018-28-1-89-93221The role of bismuth drugs in elevation of Helicobacter pylori infection eradication efficacyA. A. Sheptulin0Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical UniversityAim of review. To demonstrate modern potential of bismuth agents administration for increasing of Helicobacter pylori (H. pylori) eradication efficacy. Summary. Prevention of peptic ulcer and stomach cancer makes eradication of H. pylori infection more and more important. At the same time efficacy of some eradication modes, first of all - that of standard triple therapy, steadily decreases because of growing antibiotic resistance of H. pylori strains, first of all - clarithromycin resistance. The concept that empirical prescription of standard triple therapy should be abandoned in favor of initial H. pylori clarithromycin-resistance testing by culture or real-time polymerase chain reaction became widely accepted. Bismuth-based quadrotherapy mainly - with bismuth tripotassium dicitrate (BTD) is alternative to standard triple mode therapy nowadays. Potential of BTD combination not only to tetracycline but to other antibiotics as well was demonstrated. Addition of BTD to triple therapy containing clarithromycin, levofloxacin, metronidazole allows to increase eradication efficacy for 30-40% at H. pylori-resistant strains. Absence of H. pylori resistance development to BTD, combined antibacterial and cytoprotective effects as well as good tolerance are important advantages of the drug. Conclusion. Addition of BTD to triple H. pylori eradication modes, that include different antibiotics (clarithromycin, levofloxacin and metronidazole) provide significant increase in efficacy of eradication at antibioticresistant Helicobacter pylori strains.https://www.gastro-j.ru/jour/article/view/221helicobacter pyloriэрадикациярезистентностьвисмута трикалия дицитрат
spellingShingle A. A. Sheptulin
The role of bismuth drugs in elevation of Helicobacter pylori infection eradication efficacy
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
helicobacter pylori
эрадикация
резистентность
висмута трикалия дицитрат
title The role of bismuth drugs in elevation of Helicobacter pylori infection eradication efficacy
title_full The role of bismuth drugs in elevation of Helicobacter pylori infection eradication efficacy
title_fullStr The role of bismuth drugs in elevation of Helicobacter pylori infection eradication efficacy
title_full_unstemmed The role of bismuth drugs in elevation of Helicobacter pylori infection eradication efficacy
title_short The role of bismuth drugs in elevation of Helicobacter pylori infection eradication efficacy
title_sort role of bismuth drugs in elevation of helicobacter pylori infection eradication efficacy
topic helicobacter pylori
эрадикация
резистентность
висмута трикалия дицитрат
url https://www.gastro-j.ru/jour/article/view/221
work_keys_str_mv AT aasheptulin theroleofbismuthdrugsinelevationofhelicobacterpyloriinfectioneradicationefficacy
AT aasheptulin roleofbismuthdrugsinelevationofhelicobacterpyloriinfectioneradicationefficacy